(Q44263549)

1 December 2017

QTc interval lengthening is related to CYP2D6 hydroxylation capacity and plasma concentration of thioridazine in patients (English)

1 reference

1 December 2017

4

1 reference

1 December 2017

Adrián LLerena

1

0 references

author name string

Roland Berecz

series ordinal

2

1 reference

PubMed ID

12503836

1 December 2017

Alfredo de la Rubia

series ordinal

3

1 reference

PubMed ID

12503836

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Journal of Psychopharmacology

1 December 2017

1 reference

1 December 2017

16

1 reference

1 December 2017

4

1 reference

1 December 2017

361-364

1 reference

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology

1 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F026988110201600411

Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110201600411

Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different CYP2D6 genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110201600411

Antipsychotics and the risk of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110201600411

Molecular biology of K(+) channels and their role in cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110201600411

Electrocardiographic changes in patients receiving neuroleptic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110201600411

Cardiotoxicity More Common in Thioridazine Overdose than with Other Neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110201600411

Pharmacokinetic Interaction of Fluvoxamine and Thioridazine in Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110201600411

Use of the Mesoridazine/Thioridazine Ratio as a Marker for CYP2D6 Enzyme Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110201600411

10.1177/026988110201600411

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference

PubMed ID

12503836